ADAPTER OU NE PAS ADAPTER LA POSOLOGIE DE L'ISONIAZIDE?

Translated title of the contribution: Should Isoniazid dosage be adjusted for acetylator status?

R. Parrot, C. Boval, J. Grosset, J. P. Gaillard

Research output: Contribution to journalArticle

Abstract

Between 24 October 1977 and 31 December 1978 a series of 299 patients were treated with triple therapy - Rifampicin, Ethambutol and Isoniazid; the latter was given in a standard dose of 5 mg/kg. Between 1 January 1979 and 31 December 1981 a second series of 448 patients were treated with the same combination; Isoniazid was given in a dose adjusted for acetylator status (Vivien et coll.). In all the patients the serum concentrations of Isoniazid at 3, 6 and 12 hours (after a single oral dose of 5 mg/kg) were measured and the two series of patients were comparable. No significant difference was noted between the two groups regarding either efficacy or toxicity. The adjustment of Isoniazid dosage according to acetylator status has not resulted in any statistically significant benefit in the patients studied.

Original languageFrench
Pages (from-to)705-712
Number of pages8
JournalRevue Francaise des Maladies Respiratoires
Volume11
Issue number5
StatePublished - 1983
Externally publishedYes

Fingerprint

Isoniazid
Ethambutol
Rifampin
Serum

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Parrot, R., Boval, C., Grosset, J., & Gaillard, J. P. (1983). ADAPTER OU NE PAS ADAPTER LA POSOLOGIE DE L'ISONIAZIDE? Revue Francaise des Maladies Respiratoires, 11(5), 705-712.

ADAPTER OU NE PAS ADAPTER LA POSOLOGIE DE L'ISONIAZIDE? / Parrot, R.; Boval, C.; Grosset, J.; Gaillard, J. P.

In: Revue Francaise des Maladies Respiratoires, Vol. 11, No. 5, 1983, p. 705-712.

Research output: Contribution to journalArticle

Parrot, R, Boval, C, Grosset, J & Gaillard, JP 1983, 'ADAPTER OU NE PAS ADAPTER LA POSOLOGIE DE L'ISONIAZIDE?', Revue Francaise des Maladies Respiratoires, vol. 11, no. 5, pp. 705-712.
Parrot R, Boval C, Grosset J, Gaillard JP. ADAPTER OU NE PAS ADAPTER LA POSOLOGIE DE L'ISONIAZIDE? Revue Francaise des Maladies Respiratoires. 1983;11(5):705-712.
Parrot, R. ; Boval, C. ; Grosset, J. ; Gaillard, J. P. / ADAPTER OU NE PAS ADAPTER LA POSOLOGIE DE L'ISONIAZIDE?. In: Revue Francaise des Maladies Respiratoires. 1983 ; Vol. 11, No. 5. pp. 705-712.
@article{7dcf9604ca8941928064ab778b40affe,
title = "ADAPTER OU NE PAS ADAPTER LA POSOLOGIE DE L'ISONIAZIDE?",
abstract = "Between 24 October 1977 and 31 December 1978 a series of 299 patients were treated with triple therapy - Rifampicin, Ethambutol and Isoniazid; the latter was given in a standard dose of 5 mg/kg. Between 1 January 1979 and 31 December 1981 a second series of 448 patients were treated with the same combination; Isoniazid was given in a dose adjusted for acetylator status (Vivien et coll.). In all the patients the serum concentrations of Isoniazid at 3, 6 and 12 hours (after a single oral dose of 5 mg/kg) were measured and the two series of patients were comparable. No significant difference was noted between the two groups regarding either efficacy or toxicity. The adjustment of Isoniazid dosage according to acetylator status has not resulted in any statistically significant benefit in the patients studied.",
author = "R. Parrot and C. Boval and J. Grosset and Gaillard, {J. P.}",
year = "1983",
language = "French",
volume = "11",
pages = "705--712",
journal = "Revue des Maladies Respiratoires",
issn = "0761-8425",
publisher = "Elsevier Masson",
number = "5",

}

TY - JOUR

T1 - ADAPTER OU NE PAS ADAPTER LA POSOLOGIE DE L'ISONIAZIDE?

AU - Parrot, R.

AU - Boval, C.

AU - Grosset, J.

AU - Gaillard, J. P.

PY - 1983

Y1 - 1983

N2 - Between 24 October 1977 and 31 December 1978 a series of 299 patients were treated with triple therapy - Rifampicin, Ethambutol and Isoniazid; the latter was given in a standard dose of 5 mg/kg. Between 1 January 1979 and 31 December 1981 a second series of 448 patients were treated with the same combination; Isoniazid was given in a dose adjusted for acetylator status (Vivien et coll.). In all the patients the serum concentrations of Isoniazid at 3, 6 and 12 hours (after a single oral dose of 5 mg/kg) were measured and the two series of patients were comparable. No significant difference was noted between the two groups regarding either efficacy or toxicity. The adjustment of Isoniazid dosage according to acetylator status has not resulted in any statistically significant benefit in the patients studied.

AB - Between 24 October 1977 and 31 December 1978 a series of 299 patients were treated with triple therapy - Rifampicin, Ethambutol and Isoniazid; the latter was given in a standard dose of 5 mg/kg. Between 1 January 1979 and 31 December 1981 a second series of 448 patients were treated with the same combination; Isoniazid was given in a dose adjusted for acetylator status (Vivien et coll.). In all the patients the serum concentrations of Isoniazid at 3, 6 and 12 hours (after a single oral dose of 5 mg/kg) were measured and the two series of patients were comparable. No significant difference was noted between the two groups regarding either efficacy or toxicity. The adjustment of Isoniazid dosage according to acetylator status has not resulted in any statistically significant benefit in the patients studied.

UR - http://www.scopus.com/inward/record.url?scp=0021067917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021067917&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 705

EP - 712

JO - Revue des Maladies Respiratoires

JF - Revue des Maladies Respiratoires

SN - 0761-8425

IS - 5

ER -